A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

Studies show under-representation of children and teens with multidrug-resistant TB, calling for focused case-finding efforts ...

What is helping drive the increase of drug-resistant infections in Ukraine, why should the UK be on alert, and importantly, ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

Here we present a case of a patient with stage IV CD-74-ROS1 fusion NSCLC discovered initially with RNA next generation sequencing (NGS) who acquired ...

An international trial identified three new, all-oral drug regimens for drug-resistant tuberculosis, improving treatment ...